To assess lipid screening rates and the prevalence of dyslipidemia among children with congenital heart defects (CHD).
Approach:
Study Design: A retrospective electronic medical record study was conducted on children with CHD aged 9 to 18 years at Nationwide Children’s Hospital from 2012 to 2019.
Data Collection: Demographic information, vital signs, and lipid panels were collected from clinical encounters, focusing on those who underwent echocardiograms.
Classification: Patients were categorized into screened and unscreened groups based on lipid panel availability, and further into normolipidemic and dyslipidemic based on lipid criteria.
Key Findings:
Only 18-31% of children with CHD underwent lipid screening based on cardiac diagnosis.
Dyslipidemia rates varied significantly among different types of CHD.
Childhood lipid values can predict adult lipid levels.
Interpretation:
The study highlights low adherence to lipid screening guidelines in children with CHD and the need for improved identification of dyslipidemia in this population.
Limitations:
The study was retrospective and relied on existing medical records.
Fasting status for lipid panels was unknown, which may affect triglyceride and LDL-C levels.
Conclusion:
Understanding lipid screening and dyslipidemia in children with CHD is crucial for improving cardiovascular health outcomes.
